Analysts: Medtronic, Abbott stents to take major market share

09/6/2007 | Bloomberg

Analysts expect Abbott Laboratories' Xience and Medtronic's Endeavor drug-coated stents to grab one-third of the $5 billion stent market. "We have a new generation of stents that are easier to use and may have significant advantages in effectiveness and safety," one analyst said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ